Jim Simons Acadia Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,226,533 shares of ACAD stock, worth $21.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,226,533

Previous 403,200 204.2%

Holding current value

$21.5 Million

Previous $6.21 Million 262.71%

% of portfolio

0.04%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $11.8 Million - $15.4 Million	823,333 Added 204.2%	1,226,533 $22.5 Million
Q3 2024 Nov 13, 2024	SELL	$15.14 - $19.14 $1.1 Million - $1.39 Million	-72,800 Reduced 15.29%	403,200 $6.21 Million
Q2 2024 Aug 09, 2024	SELL	$14.62 - $18.42 $1.43 Million - $1.8 Million	-97,800 Reduced 17.04%	476,000 $7.74 Million
Q1 2024 May 13, 2024	BUY	$17.79 - $30.86 $6.93 Million - $12 Million	389,800 Added 211.85%	573,800 $10.6 Million
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $3.82 Million - $5.85 Million	184,000 New	184,000 $5.76 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $231,400 - $333,450	13,000 Added 11.04%	130,800 $3.13 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $3.23 Million - $4.14 Million	-197,900 Reduced 62.69%	117,800 $2.22 Million
Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $3.95 Million - $5.18 Million	278,000 Added 737.4%	315,700 $5.03 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $531,947 - $688,779	37,700 New	37,700 $617,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $188,645 - $394,690	-14,500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $303,630 - $398,750	14,500 New	14,500 $351,000
Q2 2021 Aug 13, 2021	SELL	$19.4 - $27.42 $11.3 Million - $15.9 Million	-581,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$25.02 - $54.99 $9.97 Million - $21.9 Million	398,600 Added 218.53%	581,000 $15 Million
Q4 2020 Feb 10, 2021	SELL	$41.04 - $56.79 $3.57 Million - $4.95 Million	-87,100 Reduced 32.32%	182,400 $9.75 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $5.73 Million - $8.97 Million	157,300 Added 140.2%	269,500 $11.1 Million
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $2.02 Million - $2.71 Million	51,400 Added 84.54%	112,200 $5.44 Million
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $21.2 Million - $31.4 Million	-670,200 Reduced 91.68%	60,800 $2.57 Million
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $23.4 Million - $33.2 Million	645,200 Added 751.98%	731,000 $31.3 Million
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $1.91 Million - $3.78 Million	85,800 New	85,800 $3.09 Million
Q1 2019 May 14, 2019	SELL	$16.17 - $27.38 $9.67 Million - $16.4 Million	-597,800 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $8.56 Million - $13.7 Million	597,800 New	597,800 $9.67 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.83B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account